Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning

NCT02308332 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Neurocognitive Decline
HIV Associated Neurocognitive Disorder

Interventions

DRUG: Eviplera

Sponsor

UMC Utrecht

Collaborators

[object Object]